ProCE Banner Activity

Emerging Therapies and Testing for METex14 in Advanced NSCLC

Slideset Download
Download this slideset for expert insight into the latest evidence on treatment options for MET exon 14 skipping mutations in NSCLC and best practices for detecting METex14 alterations.

Released: August 20, 2020

Expiration: August 19, 2021

No longer available for credit.

Share

Faculty

Karen L. Reckamp

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This educational activity is supported by an independent grant from the Healthcare business of

Merck KGaA

Faculty Disclosure

Primary Author

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California